{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3-Chymotrypsin-like protease", "Antiviral activity", "Docking", "SARS-CoV-2", "Spike glycoprotein"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33794459", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.scitotenv.2021.146400", "S0048-9697(21)01468-6"], "Journal": {"ISSN": "1879-1026", "JournalIssue": {"Volume": "781", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "10"}}, "Title": "The Science of the total environment", "ISOAbbreviation": "Sci Total Environ"}, "ArticleTitle": "Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools.", "Pagination": {"StartPage": "146400", "MedlinePgn": "146400"}, "Abstract": {"AbstractText": ["The new SARS-CoV-2, responsible for the COVID-19 pandemic, has been threatening public health worldwide for more than a year. The aim of this work was to evaluate compounds of natural origin, mainly from medicinal plants, as potential SARS-CoV-2 inhibitors through docking studies. The viral spike (S) glycoprotein and the main protease M<sup>pro</sup>, involved in the recognition of virus by host cells and in viral replication, respectively, were the main molecular targets in this study. Molecular docking was performed using AutoDock, which allowed us to select the plant actives with the highest affinity towards the viral targets and to identify the interaction molecular sites with the SARS-CoV2 proteins. The best energy binding values for S protein were, in kcal/mol: -19.22 for glycyrrhizin, -17.84 for gitoxin, -12.05 for dicumarol, -10.75 for diosgenin, and -8.12 for delphinidin. For M<sup>pro</sup> were, in kcal/mol: -9.36 for spirostan, -8.75 for N-(3-acetylglycyrrhetinoyl)-2-amino-propanol, -8.41 for \u03b1-amyrin, -8.35 for oleanane, -8.11 for taraxasterol, and -8.03 for glycyrrhetinic acid. In addition, the synthetic drugs umifenovir, chloroquine, and hydroxychloroquine were used as controls for S protein, while atazanavir and nelfinavir were used for M<sup>pro</sup>. Key hydrogen bonds and hydrophobic interactions between natural compounds and the respective viral proteins were identified, allowing us to explain the great affinity obtained in those compounds with the lowest binding energies. These results suggest that these natural compounds could potentially be useful as drugs to be experimentally evaluated against COVID-19."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Investigaciones para la Industria Qu\u00edmica (INIQUI), Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) - Universidad Nacional de Salta (UNSa), Av. Bolivia 5150, 4400 Salta, Argentina; Facultad de Ciencias Naturales, UNSa, Salta, Argentina."}], "LastName": "Z\u00edgolo", "ForeName": "Mar\u00eda Antonela", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Silentium Apps, Salta, Argentina; Facultad de Econom\u00eda y Administraci\u00f3n, Universidad Cat\u00f3lica de Salta (UCASAL), Salta, Argentina."}], "LastName": "Goytia", "ForeName": "Mat\u00edas Rivero", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Investigaciones para la Industria Qu\u00edmica (INIQUI), Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) - Universidad Nacional de Salta (UNSa), Av. Bolivia 5150, 4400 Salta, Argentina."}], "LastName": "Poma", "ForeName": "Hugo Ramiro", "Initials": "HR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Investigaciones para la Industria Qu\u00edmica (INIQUI), Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) - Universidad Nacional de Salta (UNSa), Av. Bolivia 5150, 4400 Salta, Argentina; Facultad de Ingenier\u00eda, UNSa, Salta, Argentina; Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, Singapore, Singapore. Electronic address: vbrajal@gmail.com."}], "LastName": "Rajal", "ForeName": "Ver\u00f3nica Beatriz", "Initials": "VB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Investigaciones para la Industria Qu\u00edmica (INIQUI), Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) - Universidad Nacional de Salta (UNSa), Av. Bolivia 5150, 4400 Salta, Argentina; Facultad de Ciencias Naturales, UNSa, Salta, Argentina."}], "LastName": "Irazusta", "ForeName": "Ver\u00f3nica Patricia", "Initials": "VP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Sci Total Environ", "NlmUniqueID": "0330500", "ISSNLinking": "0048-9697"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Viral"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Proteins"}, {"RegistryNumber": "30ZAG40J8N", "NameOfSubstance": "alpha-amyrin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": [], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "RNA, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Viral Proteins"}], "CoiStatement": "Declaration of competing interest The authors declare no conflict of interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbas Zaidi S., Jameel S., Jafri K., Khan S., Ahmad E. Ilaj bil hijamah (cupping therapy) in the Unani system of medicine: anecdotal practice to evidence-based therapy. Acta Med Hist Adriat. 2016;14(1):81\u201394.", "ArticleIdList": ["27598955"]}, {"Citation": "Agrawal A., Jain N.K., Kumar N., Kulkarni G.T. Chem Rxiv Preprint; 2020. Molecular Docking Study to Identify Potential Inhibitor of COVID-19 Main Protease Enzyme: an In-Silico Approach.", "ArticleIdList": ["10.26434/chemrxiv.12170904.v1"]}, {"Citation": "Alonso J. Rosario; Corpus Ediciones: 2008. Tratado de Fitof\u00e1rmacos y Nutrac\u00e9uticos. 1\u00aa. Reimpr."}, {"Citation": "Alonso J., Desmarchelier C. Ciudad Aut\u00f3noma de Buenos Aires: Corpus Libros M\u00e9dicos y Cient\u00edficos. 1a ed. 2015. Plantas Medicinales. ISBN 978-987-1860-25-8."}, {"Citation": "An L., Liu R., Tang W., Wu J.G., Chen X. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs. Antivir. Res. 2014;109:54\u201363.", "ArticleIdList": ["24971493"]}, {"Citation": "Andrei G.M., Ooulombie F.C., Courreges M.C., de Torres R.A. Coto CE Meliacine. An antiviral compound from Melia azedarach L. inhibits interferon production. J. Interf. Res. 1990;10:469\u2013475.", "ArticleIdList": ["1703195"]}, {"Citation": "Baranov P.V., Henderson C.M., Anderson C.B., et al. Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology. 2005;332:498\u2013510.", "ArticleIdList": ["PMC7111862", "15680415"]}, {"Citation": "Bruneton J. 2da ed. Zaragosa; Acribia S. A.: 2001. Farmacognosia, fitoqu\u00edmica, plantas medicinales."}, {"Citation": "Camponovo L., Bandoni A.  Buenos Aires; L\u00f3pez Etchegoyen Libreros Editores: 1955. Farmacolog\u00eda: Materia M\u00e9dica y Terap\u00e9utica.http://catalogosuba.sisbi.uba.ar/vufind/Record/201603170442292872"}, {"Citation": "Casais de Corne A., Fiz Fern\u00e1ndez A., Lardiez Gonz\u00e1lez J. N\u00famero especial. Todo es Historia. 1a Edici\u00f3n. 1997. Panorama Hist\u00f3rico de la Medicina Argentina."}, {"Citation": "Cecil C.E., Davis J.M., Cech N.B., LasterSM Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis) Int. Immunopharmacol. 2011;11:1706\u20131714.", "ArticleIdList": ["21683808"]}, {"Citation": "Cinatl J., Morgenstern M., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Clinical Trials . COVID-19 and SARS-CoV-2. 2020. N.S. National Library of Medicine USA.https://www.clinicaltrials.gov/ct2/results?cond=Covid19&term=&cntry=&state=&city=&dist (accessed 14 December 2020)"}, {"Citation": "Cort\u00e9s Gallardo V., Macedo Ceja J., Hern\u00e1ndez Arroyo M., Arteaga Aureoles G., Espinoza Galv\u00e1n D., Rodr\u00edguez Landa J. Farmacognosia: breve historia de sus or\u00edgenes y su relaci\u00f3n con las ciencias m\u00e9dicas. Rev. Biomed. 2004;15:123\u2013136."}, {"Citation": "De Clercq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 2000;20(5):323\u2013349.", "ArticleIdList": ["10934347"]}, {"Citation": "Detoc M., Bruel S., Frappe P., Tardy T., Botelho-Nevers E., Gagneux-Brunon A. Vaccine 2020. 2020. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. In press.", "ArticleIdList": ["10.1016/j.vaccine.2020.09.041", "PMC7498238", "32988688"]}, {"Citation": "Devaux C.A., Rolain J.M., Colson P., Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int. J. Antimicrob. Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105938.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105938", "PMC7118659", "32171740"]}, {"Citation": "Duraffourd C., Lapraz J., d\u2019Hervicourt L. In: Cuadernos de Fitoterapia Cl\u00ednica. Primera ed. Duraffourd C., editor. Barcelona; Edit. Masson: 1987."}, {"Citation": "Dwivedi A.P., Kumar S., Varshney V., Singh A.B., Srivastava A.K., Sahu D.P. Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines. Bioorg. Med. Chem. Lett. 2008;18(7):2301\u20132305.", "ArticleIdList": ["18353644"]}, {"Citation": "Enkhtaivan G., Kim D., Park G.S., Pandurangan M., Nicholas D.A., Moon S.H., Kadam A.A., Patel R.V., Shin H.S. Mistry BM Berberine-piperazine conjugates as potent influenza neuraminidase blocker. Int. J. Biol. Macromol. 2018;119:1204\u20131210.", "ArticleIdList": ["30099043"]}, {"Citation": "Frediansyah A., Tiwaric R., Sharun K., Dhama K., Harapan H. Antivirals for COVID-19: a critical review. Clinical Epidemiology and Global Health. 2021;9:90\u201398.", "ArticleIdList": ["PMC7831805", "33521390"]}, {"Citation": "Gorbalenya A.E., Baker S.C., Baric R.S., Groot R.J.D., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L.M., Samborskiy D.V., Sidorov L.A., Sola I., Ziebuhr J. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536\u2013544. doi: 10.1038/s41564-020-0695.", "ArticleIdList": ["10.1038/s41564-020-0695", "PMC7095448", "32123347"]}, {"Citation": "Hall D.C., Ji H.F. A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Med Infect Di. 2020:101646. doi: 10.1016/j.tmaid.2020.101646.", "ArticleIdList": ["10.1016/j.tmaid.2020.101646", "PMC7152904", "32294562"]}, {"Citation": "Hassan S.T., Masar\u010d\u00edkov\u00e1 R., Berchov\u00e1 K. Bioactive natural products with anti-herpes simplex virus properties. J. Pharm. Pharmacol. 2015;67(10):1325\u20131336.", "ArticleIdList": ["26060043"]}, {"Citation": "Haustein K.O., Markwardt F., Repke K.R. Different relationships between therapeutic and toxic actions of 16-epi-gitoxin, gitoxin and ouabain on isolated cardiac preparations. Eur. J. Pharmacol. 1970;10(1):1\u201310.", "ArticleIdList": ["5441098"]}, {"Citation": "Hegyi A., Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J Gen Virol. 2002;83(Pt 3):595\u2013599.", "ArticleIdList": ["11842254"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Kr\u00fcger N., M\u00fcller M., Drosten C., P\u00f6hlmann S. BioRxiv. 2020. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells.", "ArticleIdList": ["10.1101/2020.01.31.929042"]}, {"Citation": "Horden P. Medicine, religion and gender in medieval culture. Med. Hist. 2016;60(3):441\u2013442."}, {"Citation": "Hostettmann K., Marston A. Cambridge University Press; Cambridge: 1995. Chemistry and Pharmacology of Natural Products."}, {"Citation": "Jahanshahlu L., Rezaei N. Monoclonal antibody as a potential anti-COVID-19. Biomed. Pharmacother. 2020;129:110337.", "ArticleIdList": ["PMC7269943", "32534226"]}, {"Citation": "Jin Z., Du X., Xu Y., et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. 2020 doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Kaliyaperumal S., Periyasamy K., Balakrishnan U., Palanivel P., Egbuna C. In: Phytochemicals as Lead Compounds for New Drug Discovery. Egbuna C., Kumar S., Ifemeje J.C., Ezzat S.M., Kaliyaperumal S., editors. Elsevier; Amsterdam: 2020. Chapter 15 - antiviral phytocompounds for drug development: a data mining studies; pp. 239\u2013244."}, {"Citation": "Kaur S.P., Gupta V. COVID-19 Vaccine: a comprehensive status report. Virus Res. 2020;288:198114. doi: 10.1016/j.virusres.2020.198114.", "ArticleIdList": ["10.1016/j.virusres.2020.198114", "PMC7423510", "32800805"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. 2020. Potential Inhibitor of COVID-19 Main Protease (Mpro) from Several Medicinal Plant Compounds by Molecular Docking Study. Preprints.", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Kontogiorgis C.A., Hadjipavlou-Litina D.J. Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg. Med. Chem. 2004;14(3):611\u2013614. published correction appears in.", "ArticleIdList": ["14741253"]}, {"Citation": "Krajcovicova Z., Krajcovicova A., Vach\u00e1lkov\u00e1 K. Horv\u00e1thov\u00e1. Taraxasterol and beta-sitosterol: new naturally compounds with chemoprotective/chemopreventive effects. Neoplasma. 2004;51(6):407\u2013414.", "ArticleIdList": ["15640948"]}, {"Citation": "Liu C., Tang J., Ma Y., Liang X., Yang Y., et al. Receptor usage and cell entry of porcine epidemic diarrhea coronavirus. J. Virol. 2015;89:6121\u20136125.", "ArticleIdList": ["PMC4442452", "25787280"]}, {"Citation": "Luengo-Fernandez R., Gray A.M., Rothwell P.M. American Heart Association; Inc.: 2008. Costs of Stroke Using Patient-Level Data a Critical Review of the Literature.", "ArticleIdList": ["10.1161/STROKEAHA.108.529776", "19109540"]}, {"Citation": "Malik A.A., McFaddena S.M., Elharakea J., Omera S.B. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.", "ArticleIdList": ["PMC7423333", "32838242"]}, {"Citation": "Morris G.M., Lim-Wilby M. In: Molecular docking. Kukol A., editor. Vol. 443. Humana Press; 2008. pp. 365\u2013382.", "ArticleIdList": ["18446297"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. Software news and updates. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791.", "ArticleIdList": ["PMC2760638", "19399780"]}, {"Citation": "Pecetta S., Finco O., Seubert A. Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era. Semin. Immunol. 2020 doi: 10.1016/j.smim.2020.101427. Journal Pre-proof.", "ArticleIdList": ["10.1016/j.smim.2020.101427", "PMC7670927", "33277154"]}, {"Citation": "Pellecuer J. Vol. 32. Universidad de Montpellier. Natura Medicatrix; 1993. Investigaci\u00f3n Cient\u00edfica en Fitoterapia: de la planta al medicamento; pp. 21\u201324."}, {"Citation": "P\u00e9rez-Labrada K., Brouard I., Est\u00e9vez S., Marrero M.T., Est\u00e9vez F., Bermejo J., Rivera D.G. New insights into the structure\u2013cytotoxicity relationship of spirostan saponins and related glycosides. Bioorg. Med. Chem. 2012;20:2690\u20132700.", "ArticleIdList": ["22405922"]}, {"Citation": "Rawat K., Kumari P., Saha L. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. Eur. J. Pharmacol. 2020 doi: 10.1016/j.ejphar.2020.173751. Journal Pre-proof.", "ArticleIdList": ["10.1016/j.ejphar.2020.173751", "PMC7685956", "33245898"]}, {"Citation": "Roy A., Saraf S. Limonoids: overview of significant bioactive triterpenes distributed in plants kingdom. Biol. Pharm. Bull. 2006;29(2):191\u2013201.", "ArticleIdList": ["16462017"]}, {"Citation": "Sampangi-Ramaiah M.H., Vishwakarma R., Shaanker U. Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease. Curr. Sci. 2020;118(7):1087\u20131092."}, {"Citation": "Sharapin N., Machado L., Souza E., de Albuquerque E., Valverde E., L\u00f3pez J.M. Santa Fe de Bogot\u00e1: Convenio Andr\u00e9s Bello y Red Iberoamericana de Productos Fitofarmac\u00e9uticos (RIPROFITO) del Subprograma X de CYTED. 2000. Fundamentos de tecnolog\u00eda de productos fitoterap\u00e9uticos; p. 17."}, {"Citation": "Shin H.B., Choi M.S., Yi C.M., Lee J., Kim N.J., Inn K.S. Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine. Int. Immunopharmacol. 2015;27:65\u201368.", "ArticleIdList": ["25939536"]}, {"Citation": "Stefanachi A., Favia A.D., Nicolotti O., et al. Design, synthesis, and biological evaluation of imidazolyl derivatives of 4, 7-disubstituted coumarins as aromatase inhibitors selective over 17-\u03b1-hydroxylase/C17-20 lyase. J. Med. Chem. 2011;54(6):1613\u20131625.", "ArticleIdList": ["21341743"]}, {"Citation": "Walls A.C., Tortorici M.A., Bosch B.J., Frenz B., Rottier P.J., et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature. 2016;531:114\u2013117.", "ArticleIdList": ["PMC5018210", "26855426"]}, {"Citation": "Wang W.J., Yang T., Chen H., Xu Y.N., Yu L.F., Liu T., Tang J., Yi Z., Yang C.G., Xue W., Yang F. The synthesis and antistaphylococcal activity of 9, 13-disubtituted berberine derivatives. Eur. J. Med. Chem. 2017;127:424\u2013433.", "ArticleIdList": ["28092858"]}, {"Citation": "Whang D., Zigang Li, Liu Y. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. Journal of Infection and Public Health. 2020;13:1405\u20131414.", "ArticleIdList": ["PMC7357519", "32684351"]}, {"Citation": "White N.J., Pukrittayakamee S., Hien T.T., Faiz M.A., Mokuolu O.A., Dondorp A.M. Malaria. Lancet. 2014;383:723\u2013735.", "ArticleIdList": ["23953767"]}, {"Citation": "World Health Organization Coronavirus Disease 2019 (COVID-19): Weekly Epidemiological Update - 9 February 2021. 2020. https://www.who.int/publications/m/item/weekly-epidemiological-update---9-february-2021"}, {"Citation": "Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., JS McLellan, editors. Science Report. 2020. Cryo EM structure of the 2019-nCoV spike in the prefusion conformation.", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Yang J., Liu G.Y., Dai F., et al. Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents. Bioorg. Med. Chem. Lett. 2011;21(21):6420\u20136425.", "ArticleIdList": ["21920747"]}, {"Citation": "Yang L., Wen K.S., Ruan X., Zhao Y.X., Wei F., Wang Q. Response of plant secondary metabolites to environmental factors. Molecules. 2018;23(4):1\u201326.", "ArticleIdList": ["PMC6017249", "29584636"]}, {"Citation": "Yu D., Suzuki M., Xie L., Morris-Natschke S.L., Lee K.H. Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med. Res. Rev. 2003;23(3):322\u2013345.", "ArticleIdList": ["12647313"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Nature. 2020 doi: 10.1038/s41586-020-2223.", "ArticleIdList": ["10.1038/s41586-020-2223", "PMC7164518", "32198291"]}, {"Citation": "Zhao M. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies. Int. J. Antimicrob. Agents. 2020;55:105982. doi: 10.1016/j.ijantimicag.2020.105982.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105982", "PMC7161506", "32305588"]}, {"Citation": "Ziebuhr J., Snijder E.J., Gorbalenya A.E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol. 2000;81:853\u2013879.", "ArticleIdList": ["10725411"]}, {"Citation": "Z\u00edgolo M.A., Salinas M., Alch\u00e9 L., Baldessari A., Garc\u00eda Li\u00f1ares G. Chemoenzymatic synthesis of new derivatives of glycyrrhetinic acid with antiviral activity. Molecular docking study. Bioorg. Chem. 2018;78:210\u2013219.", "ArticleIdList": ["29602045"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "16"}, {"Year": "2021", "Month": "2", "Day": "18"}, {"Year": "2021", "Month": "3", "Day": "5"}, {"Year": "2021", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "1", "Hour": "20", "Minute": "15"}, {"Year": "2021", "Month": "3", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33794459", "PMC7967396", "10.1016/j.scitotenv.2021.146400", "S0048-9697(21)01468-6"]}}], "PubmedBookArticle": []}